$EyePoint Pharmaceuticals(EYPT.US)$ Im looking for a pullback or to see where it goes? Its Q3 EPS was almost a 30 cents PS beat over expected.  And thier pipeline is going to have some developments. Clinical trials approach key data events with top-line Phase 2 DAVIO 2 trial results anticipated in early December, and PAVIA results in Q2 of next year. And so far the data is promising! Not to mention others advancing through trials! Now that $Outlook Therapeutics(OTLK.US)$  got a CRL...

last and probably least $bluebird bio(BLUE.US)$  all I've done is lose money on this company and will continue to do so because it's one of the first stocks i bought and I like the name , that's all for today but I will continue sharing my hot stocks in brief understandable lingo as i recognize them

$MSP Recovery(LIFW.US)$
is this expected to have another run on a monday?
also why did it run in the first place 🤔 I can't seem to find a real reason for the 300% pump?
thanks someone please respond

$Fisker(FSR.US)$  has been moving upwards ... they've produced 3000 cars with solar panels on their roofs and plan on making a lot more.. doubled daily volume today, share price up nearly 23% in the last month

$ImmunityBio(IBRX.US)$ is up 40% on the week from restructuring debt and securing a loan ... they have 13 drugs in their pipeline , many of which are in late stage trials and possibility of one gaining approval soon

$Nektar Therapeutics(NKTR.US)$  is up 21% for the week and today announced positive results from their clinicals .. trading volume has been up for 4 days

$Soleno Therapeutics(SLNO.US)$ has been moving up for the last week or so and today Oppenheimer reiterated an outperform signal so it should continue it's upward swing on Monday

$MSP Recovery(LIFW.US)$  is for real .... there was a lawsuit against them and the share price suffered , this morning that lawsuit was withdrawn .. 52 week high $1.74 .... it's at 19 cents right now